The financial burden of juvenile idiopathic arthritis: a Nova Scotia experience

Andrea Ens1, Bianca Lang, Suzanne Ramsey

  • 1IWK Health Centre, Halifax, Nova Scotia, Canada. adam.huber@iwk.nshealth.ca.

Insights

The annual cost for families managing juvenile idiopathic arthritis (JIA) is generally modest, though some face considerable expenses. Oligoarticular JIA presents lower financial burdens for families.

Area of Science:

  • Pediatric Rheumatology
  • Health Economics
  • Childhood Illnesses

Background:

  • Juvenile idiopathic arthritis (JIA) is the most prevalent rheumatic condition in children.
  • Limited data exists regarding the financial impact of JIA on affected families.
  • This study aimed to quantify the annual economic burden on families with a child diagnosed with JIA in Nova Scotia.

Purpose of the Study:

  • To determine the annual costs incurred by families caring for a child with JIA in Nova Scotia.
  • To assess the perceived financial burden and available resources among these families.

Main Methods:

  • A self-report questionnaire was distributed to families in Nova Scotia with children receiving care at the Izaak Walton Killam Health Centre's Pediatric Rheumatology Clinic in 2009.
  • The questionnaire collected data on disease-related expenses, household income, and perceived financial strain.
  • Statistical analyses included descriptive statistics, Spearman's correlation, and the Mann-Whitney U test to analyze cost relationships and group differences.

Main Results:

  • The study achieved a 31.4% response rate (54 completed questionnaires).
  • A significant portion of parents (35.9%) reported a moderate to large financial burden, with 36% perceiving their financial resources as poor.
  • The median annual cost per patient was $619.50 CAD (0.7% of median household income), with visit-related costs being the highest expense. Families with oligoarticular JIA reported significantly lower costs ($359.00 CAD) compared to other JIA subtypes ($877.00 CAD).

Conclusions:

  • While the average financial cost of JIA in Nova Scotia is modest, it can be substantial for certain families.
  • Oligoarticular JIA is associated with lower associated costs.
  • A considerable number of families experience a significant financial burden and perceive limited financial resources, highlighting the need for targeted support.
Abstract

Related Concept Videos

Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...